ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

210
Analysis
Health Care • India
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
bearish•MSCI ACWI Index
•20 Dec 2018 22:08

Global Markets Deteriorating...Except EM

With U.S. markets stumbling, the MSCI ACWI index is breaking down to new lows: defensive Sectors remain attractive. Relative to MSCI ACWI however,...

Logo
1k Views
Share
bearish•Aurobindo Pharma
•11 Dec 2018 02:50

India Generic Drugs: US Antitrust Inquiry Widens

The US government's antitrust investigation of the generic drug industry has been quiet for more than a year and has resurfaced with a...

Share
•05 Nov 2018 22:59

EM Strategy: Brazil Breaking Out, EM Energy Remains Attractive

While the MSCI EM index remains in a well-defined downtrend, and we continue to recommend selectivity, we highlight several investable themes and...

Logo
632 Views
Share
•01 Oct 2018 05:35

EM Strategy: Russia and Thailand Bullishly Inflecting; Pullback Opportunity in India

This report highlights actionable themes across the EM universe, including: bullish inflections in the Russian and Thai markets, and a pullback...

Logo
563 Views
Share
bearish•Cross Asset Strategy
•01 Apr 2025 09:51

Asian Alpha Hedge Fund (AAHF): INTRODUCTION

Asian Alpha Hedge Fund (AAHF) returned 32% in the first quarter of 2025.  The fund outperformed the MSCI All Country Asia Pacific index by 28%. ...

Logo
147 Views
Share
x